Curis Lifesciences (NSE:CURIS) Beta: N/A (As of Jun. 29, 2026)


NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
19 GF Score
Price ₹102.00
! 2 Warning Signs
View Full Analysis

What is Curis Lifesciences Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-29), Curis Lifesciences's Beta is Not available.


Curis Lifesciences  (NSE:CURIS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Curis Lifesciences Beta Related Terms


Curis Lifesciences Beta Historical Data

* Premium members only.

The historical data trend for Curis Lifesciences's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Lifesciences Beta Chart

Curis Lifesciences Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Beta
0.00 0.00 0.00 0.00

Curis Lifesciences Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
Beta 0.00 0.00 0.00 0.00
NSE:CURIS
19GF Score
Curis Lifesciences Ltd NSE:CURIS
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
19GF Score

Get the complete analysis for NSE:CURIS

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹102.00
Price